Renal Group
The Director E2E Intercompany Process Excellence & Transformation Lead drives global standardization, operational excellence, and transformation across the end-to-end Intercompany value chain. This role serves as the primary transformation authority supporting the Intercompany Global Process Owner, ensuring standards are translated into implemented solutions and scalable operating models. The position acts as a critical link between Intercompany process strategy, Finance operations, and system enablement to align operational flows with accounting outcomes.
At the Renal Group, we are strong advocates for your health as we continually explore new medicines and technologies. We provide treatment in Nephrology and Hypertension.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Renal Group.
Renal Group didn’t post a salary, so this is our estimate from similar listings.
3% above the average for this role